Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer

Oncotarget. 2015 Sep 15;6(27):23445-61. doi: 10.18632/oncotarget.4352.


Cancer cells exhibit altered metabolism including aerobic glycolysis that channels several glycolytic intermediates into de novo purine biosynthetic pathway. We discovered increased expression of phosphoribosyl amidotransferase (PPAT) and phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) enzymes of de novo purine biosynthetic pathway in lung adenocarcinomas. Transcript analyses from next-generation RNA sequencing and gene expression profiling studies suggested that PPAT and PAICS can serve as prognostic biomarkers for aggressive lung adenocarcinoma. Immunohistochemical analysis of PAICS performed on tissue microarrays showed increased expression with disease progression and was significantly associated with poor prognosis. Through gene knockdown and over-expression studies we demonstrate that altering PPAT and PAICS expression modulates pyruvate kinase activity, cell proliferation and invasion. Furthermore we identified genomic amplification and aneuploidy of the divergently transcribed PPAT-PAICS genomic region in a subset of lung cancers. We also present evidence for regulation of both PPAT and PAICS and pyruvate kinase activity by L-glutamine, a co-substrate for PPAT. A glutamine antagonist, 6-Diazo-5-oxo-L-norleucine (DON) blocked glutamine mediated induction of PPAT and PAICS as well as reduced pyruvate kinase activity. In summary, this study reveals the regulatory mechanisms by which purine biosynthetic pathway enzymes PPAT and PAICS, and pyruvate kinase activity is increased and exposes an existing metabolic vulnerability in lung cancer cells that can be explored for pharmacological intervention.

Keywords: amplification; glutamine; lung adenocarcinoma; purine biosynthesis; xenograft.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / metabolism*
  • Aged
  • Amidophosphoribosyltransferase / metabolism*
  • Aneuploidy
  • Animals
  • Biomarkers, Tumor / metabolism
  • Carboxy-Lyases / metabolism*
  • Cell Line, Tumor
  • Cell Proliferation
  • Chickens
  • Diazooxonorleucine / chemistry
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Glutamine / chemistry
  • Glutamine / metabolism
  • Humans
  • Lung Neoplasms / metabolism*
  • Male
  • Mice
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Oligonucleotide Array Sequence Analysis
  • Peptide Synthases / metabolism*
  • Prognosis
  • Purines / chemistry


  • Biomarkers, Tumor
  • Purines
  • Diazooxonorleucine
  • Glutamine
  • Amidophosphoribosyltransferase
  • Carboxy-Lyases
  • phosphoribosylaminoimidazole carboxylase
  • Peptide Synthases
  • phosphoribosylaminoimidazole-succinocarboxamide synthetase
  • purine